315(top 1%)
papers
19.7K(top 1%)
citations
74(top 1%)
h-index
133(top 1%)
g-index
335
all documents
21.3K
doc citations
1.8K
citing journals

Top Articles

#TitleJournalYearCitations
168Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of CancerJournal of Nuclear Medicine2019874
2225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate CancerJournal of Nuclear Medicine2016741
3Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation ProteinJournal of Nuclear Medicine2018522
4PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Journal of Nuclear Medicine2016475
568Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various CancersJournal of Nuclear Medicine2019468
6Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging2007467
7A Tumor-Imaging Method Targeting Cancer-Associated FibroblastsJournal of Nuclear Medicine2018453
8Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate CancerJournal of Nuclear Medicine2015451
9Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging2017425
10F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging2017421
11Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathyNature Medicine2012414
12Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose FindingJournal of Nuclear Medicine2017367
13The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor LesionsJournal of Nuclear Medicine2015332
14Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor ControlJournal of Nuclear Medicine2018322
15Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapyEuropean Journal of Nuclear Medicine and Molecular Imaging2014319
16213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experienceEuropean Journal of Nuclear Medicine and Molecular Imaging2014316
17Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experienceEuropean Journal of Nuclear Medicine and Molecular Imaging2014290
18[68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECHEuropean Journal of Nuclear Medicine and Molecular Imaging2012284
19Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor RetentionJournal of Nuclear Medicine2019281
20An Overview of Targeted Alpha Therapy with 225Actinium and 213BismuthCurrent Radiopharmaceuticals2018248
21Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyJournal of Nuclear Medicine2019238
22Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imagingEuropean Journal of Nuclear Medicine and Molecular Imaging2017234
23Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptorJournal of Hepatology2014217
24Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor InteractionJournal of Virology2010201
25The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate CancerJournal of Nuclear Medicine2016200
2668Ga-PSMA-11 PET/CT: a new technique with high potential for the radiotherapeutic management of prostate cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging2016194
27E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETEuropean Journal of Nuclear Medicine and Molecular Imaging2021188
28Preclinical Evaluation of 18F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer ImagingJournal of Nuclear Medicine2017186
29The Pharmacokinetics of Cell-Penetrating PeptidesMolecular Pharmaceutics2010176
30Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse ModelsJournal of Nuclear Medicine2020176
31SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine TumorsMolecular Imaging and Biology2015172
3268Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human ExperienceJournal of Nuclear Medicine2017166
33PSMA Ligands for PET Imaging of Prostate CancerJournal of Nuclear Medicine2017165
34Prostate-Specific Membrane Antigen Ligands for Imaging and TherapyJournal of Nuclear Medicine2017163
35FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer PatientsJournal of Nuclear Medicine2021163
36New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and TherapyClinical Cancer Research2016155
37Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA InhibitorsJournal of Medicinal Chemistry2016150
38Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging2016148
39Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timingEuropean Journal of Nuclear Medicine and Molecular Imaging2016143
40The Latest Developments in Imaging of Fibroblast Activation ProteinJournal of Nuclear Medicine2021143
41Intraindividual Comparison of 18F-PSMA-1007 and 18F-DCFPyL PET/CT in the Prospective Evaluation of Patients with Newly Diagnosed Prostate Carcinoma: A Pilot StudyJournal of Nuclear Medicine2018140
42Radiation Dosimetry and Biodistribution of 68Ga-FAPI-46 PET Imaging in Cancer PatientsJournal of Nuclear Medicine2020136
43Targeting of activated fibroblasts for imaging and therapyEJNMMI Radiopharmacy and Chemistry2019134
44Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMAEuropean Urology2021128
45Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIEuropean Journal of Nuclear Medicine and Molecular Imaging2017124
46Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective studyLancet Oncology, The2021120
47Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancersEuropean Journal of Nuclear Medicine and Molecular Imaging2020119
4818F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular ImagingTheranostics2020117
49Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na+‐taurocholate cotransporting polypeptide knockout miceHepatology2015116
50Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging2018116